Trading Signals: BMY Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(Bristol-Myers Squibb Company)
| BMY latest price $50.1000 (1.46%) ($48.9300 - $50.1800) on Fri. Dec. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.45% (three month average) | RSI | 46 | Latest Price | $50.1000(1.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BMY advances 0.1% a day on average for past five trading days. | Weekly Trend | BMY declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BMY advance at 0% a week (0% probability) SPLV(77%) XLV(76%) XLP(75%) IVE(74%) XAR(72%) | Factors Impacting BMY price | BMY will decline at least -0.725% in a week (0% probabilities). VIXM(-42%) BNDX(-41%) UUP(-20%) BND(-13%) IGOV(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.725% (StdDev 1.45%) | Hourly BBV | 2.5 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $44.52(-11.14%) | Resistance Level | $50.33 | 5 Day Moving Average | $49.23(1.77%) | 10 Day Moving Average | $49.35(1.52%) | 20 Day Moving Average | $50.33(-0.46%) | To recent high | -19.2% | To recent low | 3.3% | Market Cap | $112.922b | | | | Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |